Creating vaccines for flu challenge trials
Task V02: Manufacture of Influenza for Human Challenge Clinical Trials
This study is all about creating and testing new flu vaccines to help make them safer and more effective for people, so we can better protect everyone from getting sick.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10269863 on NIH RePORTER |
What this research studies
This research focuses on the manufacturing and characterization of vaccines specifically for clinical trials involving influenza. It involves developing and optimizing vaccine candidates, ensuring compliance with regulatory standards, and preparing materials for human challenge studies. Patients may benefit from this research as it aims to enhance the development of effective vaccines against influenza, potentially leading to better prevention strategies. The approach includes rigorous product development planning and technical audits to ensure safety and efficacy.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals who are at risk for influenza or those interested in contributing to vaccine development.
Not a fit: Patients who are not at risk for influenza or those who have contraindications to vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against influenza, improving public health outcomes.
How similar studies have performed: Previous research has shown success in developing vaccines through similar manufacturing and characterization approaches, indicating a promising pathway for this project.
Where this research is happening
New York, United States
- International AIDS Vaccine Initiative — New York, United States (Active)
Researchers
- Principal investigator: Hassell, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassell, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.